Robert E. Corringham,Joyce K. James,Patrick B. O'Donnell,Patrick B. ODonnell
申请号：
US14489290
公开号：
US09555040B2
申请日:
2014.09.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided herein are methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients, including a specific patient population. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.
